Mode
Text Size
Log in / Sign up

Systematic review on port-site metastases after laparoscopy in advanced ovarian cancer

Systematic review on port-site metastases after laparoscopy in advanced ovarian cancer
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider that port-site metastases after laparoscopy in advanced ovarian cancer may reflect aggressive disease biology rather than independently worsening survival.

This is a systematic review and case report examining port-site metastases after diagnostic laparoscopy in patients with advanced ovarian cancer. The review included five eligible studies and one case report from specialized centers. The authors synthesized findings on port-site metastasis incidence, risk factors, oncologic outcomes, and management strategies.

The review reports a wide variability in port-site metastasis incidence, ranging from 1.18% to 46.7%. Risk factors identified included advanced FIGO stage, large-volume ascites, extensive peritoneal disease, and institutional expertise. The authors argue that port-site metastases do not appear to independently affect overall survival, acting instead as a surrogate marker of aggressive disease biology.

Regarding management, routine port-site resection achieved effective local control but was associated with a significantly increased risk of wound-related morbidity, without a demonstrated survival benefit. A case report noted a serious adverse event of a late-onset giant port-site metastasis that precluded surgical management.

Key limitations noted by the authors include the wide variability in port-site metastasis incidence depending on detection method and study design. The authors conclude that diagnostic laparoscopy remains an oncologically safe and cost-effective tool when appropriately performed in specialized centers, with benefits outweighing risks in a standardized surgical pathway.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundDiagnostic laparoscopy is widely used in advanced ovarian cancer to assess resectability and avoid futile laparotomies. However, concerns persist regarding the risk of port-site metastases (PSM), a complication that remains poorly characterized, particularly in terms of clinical impact and management.MethodsWe report a case of late-onset giant port-site metastasis occurring after diagnostic laparoscopy in a patient with advanced high-grade serous ovarian cancer. In addition, we conducted a systematic review of the literature according to PRISMA guidelines, including studies reporting PSM after laparoscopy in advanced ovarian cancer. Data on incidence, risk factors, surgical techniques, oncologic outcomes, and management strategies were extracted and analyzed.ResultsThe reported case illustrates an uncommon but clinically challenging presentation of delayed, rapidly progressive PSM that ultimately precluded surgical management. The systematic review included five eligible studies and revealed a wide variability in PSM incidence, ranging from 1.18% to 46.7%, depending on detection method and study design. Advanced FIGO stage, large-volume ascites, extensive peritoneal disease, and institutional expertise emerged as the main risk factors. Importantly, PSM did not appear to independently affect overall survival, acting instead as a surrogate marker of aggressive disease biology. Routine port-site resection achieved effective local control but was associated with a significantly increased risk of wound-related morbidity, without a demonstrated survival benefit.ConclusionsPSM following diagnostic laparoscopy in advanced ovarian cancer are more frequent than clinically appreciated when histologically assessed but do not appear to adversely influence prognosis beyond underlying disease burden. Routine port-site excision should be carefully weighed against its associated morbidity. Diagnostic laparoscopy remains an oncologically safe and cost-effective tool when appropriately performed in specialized centers, and its benefits outweigh the risks when integrated into a standardized surgical pathway.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.